US · WRBY
Warby Parker Inc.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- New York City, NY 10013
- Website
- warbyparker.com
Price · as of 2025-12-31
$23.08
Market cap 3.06B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $42.30 | +83.28% |
| Intrinsic Value(DCF) | $12.83 | -44.41% |
| Graham-Dodd Method(GD) | $3.07 | -86.72% |
| Graham Formula(GF) | $0.28 | -98.81% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $0.26 | $0.00 | |||
| 2021 | $24.37 | $48.02 | $420.43 | $0.00 | $0.00 |
| 2022 | $11.04 | $35.78 | $2.23 | $0.00 | $0.00 |
| 2023 | $12.15 | $27.82 | $2.22 | $0.00 | $0.00 |
| 2024 | $21.11 | $35.30 | $0.17 | $1.98 | $0.00 |
| 2025 | $26.29 | $42.30 | $6.10 | $3.06 | $0.28 |
AI valuation
Our deep-learning model estimates Warby Parker Inc.'s (WRBY) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $42.30
- Current price
- $23.08
- AI upside
- +83.28%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$12.83
-44.41% upside
Graham-Dodd
$3.07
-86.72% upside
Graham Formula
$0.28
-98.81% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| WRBY | Warby Parker Inc. | $23.08 | 3.06B | +83% | -44% | -87% | -99% | 1965.26 | 8.77 | 3.70 | 59.48 | — | 8.77 | 53.97% | -0.61% | 0.19% | 0.46% | -0.92% | 0.23% | 0.63 | — | 2.35 | 1.93 | -1.00 | -10771.00% | 1304.00% | 2600.00% | 1.36% | 0.74 | 13.98% | 0.00% | 0.00% | 0.76% | -594.41 | 72.52 | 3.64 | 5.67 |
| BEAM | Beam Therapeutics Inc. | $28.46 | 2.89B | +40% | +284% | -70% | — | -35.47 | 2.29 | 20.31 | -63.04 | — | 2.29 | 84.05% | -274.57% | -57.24% | -8.11% | -231.66% | -6.19% | 0.24 | -8.77 | 13.09 | 12.85 | 0.04 | -8231.00% | 12001.00% | 108.00% | -12.69% | -3.56 | -217.38% | 0.00% | 0.00% | 0.00% | -4.92 | -5.24 | 13.50 | 5.65 |
| BHC | Bausch Health Companies I… | $5.93 | 2.2B | +958% | +67% | — | +6% | 18.37 | -3.99 | 0.21 | 7.14 | — | -0.13 | 68.33% | 20.07% | 1.51% | -13.10% | 4.28% | 0.45% | -38.35 | 1.37 | 1.47 | 0.88 | 6.42 | -41538.00% | 711.00% | -2040.00% | 45.49% | 0.34 | 5.18% | 0.00% | 0.00% | 34.48% | 10.68 | 22.02 | 2.14 | 0.28 |
| CON | Concentra Group Holdings … | $23.96 | 3.07B | +123% | -60% | — | +21% | 17.38 | 7.64 | 1.39 | 8.47 | — | -2.26 | 28.34% | 96.50% | 7.99% | 51.66% | 111.32% | 6.42% | 1.37 | 19.10 | 1.14 | 1.00 | 1.12 | 0.00% | 1385.00% | 3283.00% | 9.30% | 0.83 | 19.29% | 0.00% | 0.00% | 43.58% | 1.66 | 12.39 | 1.60 | 4.00 |
| HAE | Haemonetics Corporation | $63.32 | 2.96B | -0% | -52% | -67% | -37% | 21.15 | 4.32 | 2.61 | 12.54 | 47.48 | -14.83 | 57.21% | 16.30% | 12.32% | 18.83% | 10.54% | 7.22% | 1.49 | 22.76 | 1.62 | 0.88 | 2.58 | 4454.00% | 395.00% | 2338.00% | 4.02% | 0.31 | 8.56% | 0.00% | 0.00% | 6.34% | 20.13 | 31.34 | 3.28 | 2.54 |
| ICUI | ICU Medical, Inc. | $150.58 | 3.72B | -14% | -61% | -83% | -100% | 4947.86 | 1.71 | 1.62 | 14.41 | — | -381.73 | 36.76% | 4.80% | 0.03% | 0.04% | 1.32% | 0.02% | 0.66 | 1.01 | 2.36 | 0.98 | 3.32 | -10061.00% | -638.00% | -2636.00% | 2.53% | 0.36 | 2.82% | 0.00% | 0.00% | 7.11% | 44.00 | 51.26 | 2.11 | 2.21 |
| ITGR | Integer Holdings Corporat… | $86.68 | 3.04B | -17% | -60% | -62% | -46% | 29.17 | 1.72 | 1.62 | 14.64 | — | -15.81 | 26.99% | 12.93% | 5.55% | 6.11% | 6.77% | 3.17% | 0.80 | 5.55 | 3.32 | 1.57 | 4.62 | -1500.00% | 798.00% | 554.00% | 3.51% | 0.85 | 3.62% | 0.00% | 0.00% | 1.67% | 18.29 | 41.68 | 2.36 | 2.45 |
| LMAT | LeMaitre Vascular, Inc. | $108.18 | 2.45B | -46% | -51% | -89% | -62% | 41.10 | 5.37 | 8.23 | 25.41 | 93.35 | 7.69 | 68.63% | 23.77% | 20.03% | 13.87% | 18.60% | 9.80% | 0.55 | 254.91 | 13.14 | 10.77 | 2.40 | 4403.00% | 1363.00% | 2603.00% | 2.05% | 1.44 | 17.08% | 0.79% | 32.60% | 0.79% | 32.46 | 45.64 | 7.71 | 6.95 |
| PINC | Premier, Inc. | $28.26 | 2.34B | — | — | — | — | — | — | — | — | — | — | 73.41% | 0.11% | 2.00% | 3.56% | 0.04% | 1.91% | 0.18 | 0.06 | 0.64 | 0.55 | 0.85 | -7885.00% | -2479.00% | 4801.00% | — | 0.44 | 17.33% | — | 124.60% | — | — | — | — | — |
| QDEL | QuidelOrtho Corporation | $22.74 | 1.54B | -6% | -60% | — | — | -1.35 | 0.80 | 0.56 | -8.47 | — | -2.38 | 46.67% | -33.67% | -41.45% | -46.15% | -18.22% | -18.56% | 1.46 | -5.18 | 1.50 | 0.64 | -5.40 | -4535.00% | -189.00% | -2596.00% | -5.42% | 0.11 | -1.65% | 0.00% | 0.00% | 0.00% | -4.50 | -49.82 | 1.51 | 0.29 |
| XRAY | DENTSPLY SIRONA Inc. | $14.68 | 2.93B | +40% | -61% | — | — | -4.77 | 2.13 | 0.78 | -107.57 | — | -3.65 | 50.00% | 6.85% | -16.25% | -36.44% | 6.83% | -10.70% | 1.81 | 2.86 | 1.51 | 0.76 | -45.54 | -3304.00% | -298.00% | -6299.00% | 3.64% | 0.17 | 2.82% | 4.49% | -21.40% | 4.49% | 19.64 | 47.58 | 1.34 | 1.00 |
About Warby Parker Inc.
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
- CEO
- Neil Harris Blumenthal
- Employees
- 2.22K
- Beta
- 2.06
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($12.83 ÷ $23.08) − 1 = -44.41% (DCF, example).